balaglitazone,
Balaglitazone,
199113-98-9,
DRF-2593,
NN-2344,
Balaglitazone [INN],
5-(4-((3-methyl-4-oxo-3,4-dihydroquinazolin-2-yl)methoxy)benzyl)thiazolidine-2,4-dione,
5-[4-[[3-Methyl-4-oxo-3,4-dihydroquinazolin-2-yl]methoxy]benzyl]thiazolidine-2,4-dione,
DRF 2593,
NN2344,
NN 2344,
NNC-61-0645,
SCHEMBL242011,
CHEMBL2103991,
IETKPTYAGKZLKY-UHFFFAOYSA-N,
BCP11371,
AKOS030526698,
CS-1441,
DB12781,
SB16864,
NNC-61-2344,
HY-16086,
SC-94063,
DB-065992,
FT-0766930,
W-5414,
5-(p-((3,4-Dihydro-3-methyl-4-oxo-2-quinazolinyl)methoxy)benzyl)-2,4-thiazolidinedione,
5-[[4-[(3-methyl-4-oxoquinazolin-2-yl)methoxy]phenyl]methyl]-1,3-thiazolidine-2,4-dione,
5-[4-[[-methyl-4-oxo-3,4-dihydroquinazolin-2-yl]methoxy]benzyl]thiazolidine-2,4-dione,
(+-)-5-(p-((3,4-Dihydro-3-methyl-4-oxo-2-quinazolinyl)methoxy)benzyl)-2,4-thiazolidinedione,
2,4-Thiazolidinedione, 5-[[4-[(3,4-dihydro-3-methyl-4-oxo-2-quinazolinyl)methoxy]phenyl]methyl]-,
5-[[4-[(3,4-dihydro-3-methyl-4-oxo-2-quinazolinyl)methoxy]phenyl]methyl]-2,4-Thiazolidinedione,
1,2-Dibromohexane,
D0F3NH,
UNII-4M1609828O,
CID9889200,
DRF-2593-307,
4M1609828O,
5-[[4-[(3-methyl-4-oxo-quinazolin-2-yl)methoxy]phenyl]methyl]-1,3-thiazolidine-2,4-dione,